Correlation Between Day One and Pliant Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Pliant Therapeutics, you can compare the effects of market volatilities on Day One and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Pliant Therapeutics.

Diversification Opportunities for Day One and Pliant Therapeutics

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Day and Pliant is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Day One i.e., Day One and Pliant Therapeutics go up and down completely randomly.

Pair Corralation between Day One and Pliant Therapeutics

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 1.0 times more return on investment than Pliant Therapeutics. However, Day One is 1.0 times more volatile than Pliant Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  1,673  in Day One Biopharmaceuticals on August 27, 2024 and sell it today you would lose (301.00) from holding Day One Biopharmaceuticals or give up 17.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Pliant Therapeutics

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Pliant Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Pliant Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Pliant Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Day One and Pliant Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Pliant Therapeutics

The main advantage of trading using opposite Day One and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.
The idea behind Day One Biopharmaceuticals and Pliant Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments